GLENMARK PHARMACEUTICALS LTD. - Glenmark Pharmaceuticals receives ANDA approval for Rufinamide Tablets USP, 200 mg and 400 mg
19 May 2016
Glenmark Pharmaceuticals Ltd has submitted to BSE a copy of Press Release dated May 19, 2016 titled 'Glenmark Pharmaceuticals receives ANDA approval for Rufinamide Tablets USP, 200 mg and 400 mg'
Source:
BSE India